An Open Label Pilot Study of IV Brexanolone for the Treatment of Post-Traumatic Stress Disorder
Phase 4
20
about 2.8 years
18–50
Female only
1 site in TX
What this study is about
Researchers are testing a treatment called brexanolone, given as an injection into a vein, to see if it helps reduce symptoms of PTSD in adult women. The trial will last 1004 days and involve approximately 20 women with PTSD who are not veterans.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Brexanolone Injection [Zulresso]
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
brexanolone
injection
Primary: Change in PTSD Symptom Severity: PTSD Checklist for DSM-5 (PCL-5)
Secondary: Change in Depressive Symptoms: Montgomery-Asberg Depression Rating Scale (MADRS), Change in PTSD Subscale Symptoms: PTSD Checklist for DSM-5 (PCL-5)
Psychiatry / Mental Health